Vladimir Aladinskiy

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designBiologically active moleculesEvolutionary computation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 10, 2026
Discovery of Highly Potent and Selective, Orally Bioavailable BTK-Targeting PROTACs Featuring Novel CRBN-Binding Warheads.

|Mar 03, 2026
Molecular LEGION: incalculably large coverage of chemical space around the NLRP3 target.

Bogdan Zagribelnyy, Vladimir Aladinskiy, Nikita Bondarev

|Jul 16, 2025
Identification of Novel pan-KRAS Inhibitors via Structure-Based Drug Design, Scaffold Hopping, and Biological Evaluation.

Vladimir Aladinskiy, Alexey B Mantsyzov, Chris Kruse

|Oct 18, 2024
Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis.

Vladimir Aladinskiy, Chris Kruse, Luoheng Qin

|Aug 14, 2020
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.

Andrei A Ivashchenko, Oleg D Mitkin, Jeremy C Jones

|Sep 06, 2018
Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery.

Daniil Polykovskiy, Alexander Zhebrak, Dmitry Vetrov

Pageof 1

Frequent Collaborators

3 joint publications

Alexander Aliper

3 joint publications

Alex Zhavoronkov

3 joint publications

Feng Ren

2 joint publications

Yan Ivanenkov